#read

c-LEcta launches new high-tech enzyme for cell cultures

The Leipzig biotech scene is stepping up its game. The Kerry Group company c-LEcta presents CellTrypase, a novel enzyme designed to make biopharmaceutical manufacturing processes safer and more efficient.
07/10/2025

CellTrypase is a recombinant, trypsin-like enzyme of fungal origin. It can be seamlessly integrated into existing GMP-compliant cell culture processes. It replaces animal or classic trypsin solutions without the need for time-consuming process revalidation and fulfils the highest quality and traceability requirements. CellTrypase is manufactured in the new, GMP-certified production facility in Leipzig. With a purity of over 95 per cent and complete batch transparency, the product promises reliable performance in sensitive applications such as cell and gene therapies, vaccine development or tissue engineering. The enzyme solution is free from animal materials, ready to use, stable and easy to handle. With CellTrypase, c-LEcta is sending out a clear signal in favour of Leipzig's growing importance as a location for innovative life science technologies.

News from "c-LEcta" on 07 October 2025

The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.

Click here to access the original content